J. Pouget and S. Mather, General aspects of the cellular response to low- and high-LET radiation, European Journal of Nuclear Medicine, vol.28, issue.4, pp.541-61, 2001.
DOI : 10.1007/s002590100484

T. Back, B. Haraldsson, R. Hultborn, H. Jensen, M. Johansson et al., : A Long-Term Study of Renal Function in Nude Mice, Cancer Biotherapy & Radiopharmaceuticals, vol.24, issue.6, pp.649-580628, 2009.
DOI : 10.1089/cbr.2009.0628

J. Schwartz, J. Jaggi, O. Donoghue, J. Ruan, S. Mcdevitt et al., Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody, Physics in Medicine and Biology, vol.56, issue.3, pp.721-330031, 2011.
DOI : 10.1088/0031-9155/56/3/012

URL : http://europepmc.org/articles/pmc3034478?pdf=render

J. Jaggi, S. Seshan, M. Mcdevitt, K. Laperle, G. Sgouros et al., Renal Tubulointerstitial Changes after Internal Irradiation with ??-Particle-Emitting Actinium Daughters, Journal of the American Society of Nephrology, vol.16, issue.9, pp.2677-89, 2005.
DOI : 10.1681/ASN.2004110945

URL : http://jasn.asnjournals.org/content/16/9/2677.full.pdf

E. Song, A. Rizvi, S. Qu, C. Raja, C. Brechbiel et al., Pharmacokinetics and toxicity of (213)Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer, Cancer Biol Ther, 2007.
DOI : 10.4161/cbt.6.6.4097

URL : http://www.tandfonline.com/doi/pdf/10.4161/cbt.6.6.4097?needAccess=true

T. Behr, M. Behe, M. Stabin, E. Wehrmann, C. Apostolidis et al., High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi-versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model, Cancer Res. Epub, vol.59, issue.110611, pp.2635-2678, 1999.

D. Wild, M. Frischknecht, H. Zhang, A. Morgenstern, F. Bruchertseifer et al., Alpha-versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi- AMBA versus 177Lu-DOTA-PESIN). Cancer Res, Feb, vol.1, issue.713, pp.1009-1027, 2011.
DOI : 10.1158/0008-5472.can-10-1186

URL : http://cancerres.aacrjournals.org/content/canres/71/3/1009.full.pdf

J. Norenberg, B. Krenning, I. Konings, D. Kusewitt, T. Nayak et al., 213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model. Clinical cancer research: an official journal of the American Association for Cancer Research, Feb, vol.1, issue.123, pp.897-903, 2006.
DOI : 10.1158/1078-0432.ccr-05-1264

URL : http://clincancerres.aacrjournals.org/content/clincanres/12/3/897.full.pdf

M. Essler, F. Gartner, F. Neff, B. Blechert, R. Senekowitsch-schmidtke et al., Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis. European journal of nuclear medicine and molecular imaging, pp.602-614, 2012.

S. Kennel, R. Boll, M. Stabin, H. Schuller, and S. Mirzadeh, Radioimmunotherapy of micrometastases in lung with vascular targeted213Bi, British Journal of Cancer, vol.80, issue.1-2, pp.175-84, 1999.
DOI : 10.1038/sj.bjc.6690337

URL : http://www.nature.com/bjc/journal/v80/n1/pdf/6690337a.pdf

H. Nakamae, D. Wilbur, D. Hamlin, M. Thakar, E. Santos et al., Biodistributions, myelosuppression , and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211. Cancer Res, Mar Epub, vol.15, issue.696, pp.2408-2423, 2009.
DOI : 10.1158/0008-5472.can-08-4363

URL : http://cancerres.aacrjournals.org/content/canres/69/6/2408.full.pdf

Z. Yao, M. Zhang, K. Garmestani, D. Axworthy, R. Mallett et al., Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N?-tetraacetic acidbiotin . Clinical cancer research: an official journal of the American Association for Cancer Research, pp.3137-3183, 2004.
DOI : 10.1158/1078-0432.ccr-03-0171

URL : http://clincancerres.aacrjournals.org/content/clincanres/10/9/3137.full.pdf

C. Michel, Transport of macromolecules through microvascular walls. Cardiovascular research, pp.644-53, 1996.
DOI : 10.1016/s0008-6363(96)00064-8

URL : https://academic.oup.com/cardiovascres/article-pdf/32/4/644/735068/32-4-644.pdf

H. Sarin, Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability, Journal of Angiogenesis Research, vol.2, issue.1, pp.142040-2384, 2010.
DOI : 10.1186/2040-2384-2-14

T. Nikula, M. Curcio, M. Brechbiel, O. Gansow, R. Finn et al., A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies, Nuclear Medicine and Biology, vol.22, issue.3, 1995.
DOI : 10.1016/0969-8051(94)00126-5

C. Apostolidis, R. Molinet, G. Rasmussen, and A. Morgenstern, Production of Ac-225 from Th-229 for targeted alpha therapy, Anal Chem. Oct, vol.1, issue.77, pp.6288-91, 2005.
DOI : 10.1021/ac0580114

M. Cherel, S. Gouard, J. Gaschet, C. Sai-maurel, F. Bruchertseifer et al., 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma, Journal of Nuclear Medicine, vol.54, issue.9, pp.1597-604
DOI : 10.2967/jnumed.112.111997

P. Fraker, J. Speck, and . Jr, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril, Biochem Biophys Res Commun Feb Epub, vol.2828, issue.804, pp.849-57, 1978.
DOI : 10.1016/0006-291x(78)91322-0

Z. Gregus and C. Klaassen, Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals. Toxicology and applied pharmacology, pp.24-38, 1986.

C. Watchman, V. Bourke, J. Lyon, A. Knowlton, S. Butler et al., Spatial Distribution of Blood Vessels and CD34+ Hematopoietic Stem and Progenitor Cells Within the Marrow Cavities of Human Cancellous Bone, Journal of Nuclear Medicine, vol.48, issue.4, pp.645-54, 2007.
DOI : 10.2967/jnumed.106.035337

B. Thoolen, R. Maronpot, T. Harada, A. Nyska, C. Rousseaux et al., Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System, Toxicologic Pathology, vol.115, issue.2, pp.5-81, 2010.
DOI : 10.1177/019262339502300409

URL : http://journals.sagepub.com/doi/pdf/10.1177/0192623310386499

M. Milano, L. Constine, and P. Okunieff, Normal Tissue Tolerance Dose Metrics for Radiation Therapy of Major Organs, Seminars in Radiation Oncology, vol.17, issue.2, pp.131-4031, 2007.
DOI : 10.1016/j.semradonc.2006.11.009

T. Fliedner, D. Graessle, C. Paulsen, and K. Reimers, Structure and Function of Bone Marrow Hemopoiesis: Mechanisms of Response to Ionizing Radiation Exposure, PMID: 12396705. Epub, pp.405-431, 2002.
DOI : 10.1089/108497802760363204

H. Hackbarth and D. Harrison, Changes with Age in Renal Function and Morphology in C57BL/6, CBA/HT6, and B6CBAF1 Mice, Journal of Gerontology, vol.37, issue.5, pp.540-547, 1982.
DOI : 10.1093/geronj/37.5.540

R. Schmitt and L. Cantley, The impact of aging on kidney repair American journal of physiology Renal physiology, pp.1265-72, 2007.

B. Sandmaier, W. Bethge, D. Wilbur, D. Hamlin, E. Santos et al., Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts, Blood, vol.100, issue.1, pp.318-344, 2002.
DOI : 10.1182/blood-2001-12-0322

URL : http://www.bloodjournal.org/content/bloodjournal/100/1/318.full.pdf

W. Bethge, D. Wilbur, R. Storb, D. Hamlin, E. Santos et al., Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation. Blood, Jun, vol.15, issue.10112, pp.5068-75, 2003.
DOI : 10.1182/blood-2002-12-3867

URL : http://www.bloodjournal.org/content/bloodjournal/101/12/5068.full.pdf

J. Jurcic, S. Larson, G. Sgouros, M. Mcdevitt, R. Finn et al., Targeted Alpha-Particle Immunotherapy for Acute Myeloid Leukemia, American Society of Clinical Oncology Educational Book, vol.34, issue.1004, pp.1233-1242, 2002.
DOI : 10.14694/EdBook_AM.2014.34.e126

T. Rosenblat, M. Mcdevitt, D. Mulford, N. Pandit-taskar, C. Divgi et al., Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clinical cancer research: an official journal of the American Association for Cancer Research, pp.5303-5314, 2010.
DOI : 10.1158/1078-0432.ccr-10-0382

URL : http://clincancerres.aacrjournals.org/content/clincanres/16/21/5303.full.pdf

G. Sgouros, A. Ballangrud, J. Jurcic, M. Mcdevitt, J. Humm et al., Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia, J Nucl Med, vol.40, issue.11, pp.1935-1981, 1999.